The FDA announced on Wednesday that it has approved the first generic versions of two drugs used to treat hypertension — Cozaar (losartan potassium) and Hyzaar (losartan potassium-hydrochlorothiazide).
Like their brand-name equivalents, both generics will carry boxed warnings against using them during the second and third trimesters of pregnancy.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment